Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps...

Researchers from the Icahn School of Medicine at Mount Sinai have discovered a molecular switch in neurons that limits the regrowth of damaged axonal...

UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo NordiskIn...

Living with diabetes often means dealing with daily insulin injections. For many people, this routine is not only uncomfortable but also emotionally...

The results suggest that the five-year risk of major cardiovascular events such as heart attacks and the risk of end-stage kidney disease were reduced...

MONDAY, March 23, 2026 -- Periconceptional exposure to glucagon-like peptide-1 (GLP-1) receptor agonists is associated with increased odds of preterm...

Swansea University researchers found that perovskite solar cells can tolerate dusty fabrication environments, performing almost as well as those made...

"CASGEVY Sales" Revolutionary CRISPR-Based Therapy Redefines Treatment Landscape for Sickle Cell Disease and Beta-Thalassemia with Strong Sales...

"CASGEVY Sales" Revolutionary CRISPR-Based Therapy Redefines Treatment Landscape for Sickle Cell Disease and Beta-Thalassemia with Strong Sales...

UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo Nordisk...